News

Welcome to the future of translational and early clinical development.
Scientifically driven with access to multiple centres of excellence.
Customisable full service underpinned by the highest quality clinical conduct.
World-leading patient and healthy volunteer recruitment capabilities.
Delivering the best value solution for early clinical development.
We are pleased to announce that Charité Research Organisation GmbH has been recognised by the French Ministry of Higher Education and Research as a private enterprise providing research activities within the framework of the research tax credit scheme.
The research tax credit, also known as the CIR (Crédit d’Impôt Recherche), is a tax incentive aimed at companies carrying out research and development activities, in accordance with article 244 quater B of the French General Tax Code (CGI).
With this accreditation our French clients are now able to profit from our extensive expertise in the conduct of Phase 1-2a clinical studies and subsequently apply for a significant reduction on their tax bill.
The accreditation is valid for the years 2021, 2022 and 2023.
Get in touch with our Business Development Team to find out how Charité Research Organisation can deliver optimal value for your early clinical research projects and help you reach Proof of Concept faster.
Studienberatung
Patienten und Probanden erreichen uns unter (030) 450 539 210.
Please feel free to discuss your early clinical trials with us. Your message will be received attentively by our business development team. We come back to you with feedback from our clinicians and project management experts....
Some more text